insights_auto
Why is TNDM down 2.30%?
Dive Deeperchevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
$18.67
arrow_downward
-2.30%(-0.44) 1D
$18.67
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
$19.34
High
$19.59
Low
$18.42
Mkt. cap
1.30B
Avg. vol.
2.27M
Volume
0.00
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.93
Beta
1.66
Shares outstanding
69.58M
No. of employees
2K
Open
$19.34
High
$19.59
Low
$18.42
Mkt. cap
1.30B
Avg. vol.
2.27M
Volume
0.00
52-wk high
$29.65
52-wk low
$12.26
EPS
-$0.93
Beta
1.66
Shares outstanding
69.58M
No. of employees
2K
News stories
From web sources and news partners
Markets Media
·
32 minutes ago
NYSE Expands Network of Transfer Agents
BeInCrypto
·
58 minutes ago
Anthropic’s Amended IPO Filing in 5 Numbers Before Its Nasdaq Debut
markets.businessinsider.com
·
51 minutes ago
STARTRADER Spotlights ANTHUSD Pre-IPO CFD as Anthropic Files to List on Nasdaq
Bloomberg.com
·
11 hours ago
Nasdaq 100 Enters Correction as Megacap Results Amplify AI Fears
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com